From 1 September 2026, the prescriber accreditation requirement for hepatitis B medicines under the PBS Section 100 (s100) Highly Specialised Drugs Program will be removed. As a result, all medical and authorised nurse practitioners will be able to prescribe hepatitis B antiviral treatment without additional specialist accreditation. ASHM is currently updating its website, education and resources to reflect this change.

Find out more

Back

Australian PrEP Guidelines

First published:

2017

Last published:

August 2025

Overview

Discover the updated 2025 Australian PrEP Guidelines, a comprehensive online resource for healthcare professionals. These guidelines have undergone rigorous review and updating by the PrEP Guidelines Panel and the PrEP Guidelines Reviewing Committee. They provide essential recommendations to support clinicians in prescribing PrEP using approved coformulated tenofovir and emtricitabine medications, as well as bioequivalent generic drugs available through self-importation, private prescription, or participation in Australian PrEP clinical trials.

Stay informed and enhance your practice with the latest recommendations for prescribing PrEP in Australian clinical contexts. Explore the updated Australian PrEP Guidelines to ensure optimal care for individuals at risk of HIV infection.